{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:50:06Z","timestamp":1791348606757,"version":"4.3.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xphs.2026.104482","type":"journal-article","created":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:23:03Z","timestamp":1787494983000},"page":"104482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Excipient nitrite levels are not static material attributes: Nitrite generation from environmental NOx and implications for drug product manufacturing"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6883-4812","authenticated-orcid":false,"given":"Rok","family":"Grahek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6871-5844","authenticated-orcid":false,"given":"Simona","family":"Peterlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0519-5626","authenticated-orcid":false,"given":"Monika","family":"Malovrh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1655-5238","authenticated-orcid":false,"given":"Pia","family":"Rep\u0161e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7178-8936","authenticated-orcid":false,"given":"Holger","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4799-1086","authenticated-orcid":false,"given":"Joerg","family":"Schlingemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5598-6245","authenticated-orcid":false,"given":"Malcolm","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2026.104482_bib0001","doi-asserted-by":"crossref","DOI":"10.1021\/acs.oprd.3c00100","article-title":"The nitrosamine \u201csaga\u201d: lessons learned from five years of scrutiny","author":"Nudelman","year":"2023","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2026.104482_bib0002","doi-asserted-by":"crossref","DOI":"10.1021\/acs.oprd.3c00153","article-title":"Formation of N-nitrosamine drug substance related impurities in medicines: a regulatory perspective on risk factors and mitigation strategies","author":"Cioc","year":"2023","journal-title":"Org Process Res Dev"},{"issue":"5","key":"10.1016\/j.xphs.2026.104482_bib0003","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.xphs.2022.12.022","article-title":"Regulatory experiences with root causes and risk factors for nitrosamine impurities in pharmaceuticals","volume":"112","author":"Horne","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104482_bib0004","unstructured":"EMA\/CHMP. Procedure under Article 5(3) of Regulation EC (No) 726\/2004; Assessment Report: Nitrosamine Impurities in Human Medicinal Products (EMA\/369136\/2020). Available at: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/nitrosamines-emea-h-a53-1490-assessment-report_en.pdf. Accessed 06 OCT."},{"issue":"4","key":"10.1016\/j.xphs.2026.104482_bib0005","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1208\/s12249-011-9677-z","article-title":"Reactive impurities in excipients: profiling, identification and mitigation of drug\u2013excipient incompatibility","volume":"12","author":"Wu","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2026.104482_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121740","article-title":"Avoiding N-nitrosodimethylamine formation in metformin pharmaceuticals by limiting dimethylamine and nitrite","volume":"620","author":"Schlingemann","year":"2022","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2026.104482_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082015","article-title":"Modeling the impact of excipients selection on nitrosamine formation towards risk mitigation","volume":"15","author":"Berardi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104482_bib0008","unstructured":"Asahi Kasei. Ceolus\u2122 MCC Keeps Nitrites to 0.1 ppm. 2025. https:\/\/www.ceolus.com\/en\/lp\/low_nitrite\/."},{"key":"10.1016\/j.xphs.2026.104482_bib0013","author":"Pharma"},{"issue":"6","key":"10.1016\/j.xphs.2026.104482_bib0016","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.xphs.2022.04.016","article-title":"A nitrite excipient database: a useful tool to support N-nitrosamine risk assessments for drug products","volume":"112","author":"Boetzel","year":"2022","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104482_bib0017","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ajcnut.2025.01.031","article-title":"Nitrate and nitrite food composition database: an update and extensive deep dive","volume":"121","author":"Zhong","year":"2025","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"10.1016\/j.xphs.2026.104482_bib0018","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1021\/acs.oprd.4c00037","article-title":"Nitrite in pharmaceutical manufacturing water: development of an ultra-sensitive analytical method, typical data, and discussion of potential nitrosamine formation in drug substance and drug product from water","volume":"28","author":"Suresh Kumar","year":"2024","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2026.104482_bib0019","series-title":"Method for Refining Hydroxyethylcellulose","author":"Lu","year":"2012"},{"key":"10.1016\/j.xphs.2026.104482_bib0020","unstructured":"Ross M. Nitric acid used in the production of hydroxyethylcellulose, as confirmed by supplier, has led to nitrite levels exceeding 10 ppm. 2026."},{"key":"10.1016\/j.xphs.2026.104482_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2026.104296","article-title":"Something in the air\u2212Unveiling the role of atmospheric nitrogen oxides in nitrosamine formation from amine-containing APIs: mechanistic insights and risk assessment","author":"Grahek","year":"2026","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104482_bib0022","series-title":"Atmospheric Chemistry and Physics: From Air Pollution to Climate Change","author":"Seinfeld","year":"2016"},{"issue":"1","key":"10.1016\/j.xphs.2026.104482_bib0023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/j.2050-0416.1986.tb04373.x","article-title":"The chemistry of nitrosamine formation: relevance to malting and brewing","volume":"92","author":"Wainright","year":"1986","journal-title":"J Inst Brew"},{"key":"10.1016\/j.xphs.2026.104482_bib0024","doi-asserted-by":"crossref","DOI":"10.1021\/acs.oprd.3c00274","article-title":"N-nitrosodimethylamine formation in metformin drug products by reaction of dimethylamine and atmospheric NO2","author":"Fukuda","year":"2023","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2026.104482_bib0025","doi-asserted-by":"crossref","DOI":"10.1021\/acs.oprd.5c00182","article-title":"Three-pronged approach (active pharmaceutical ingredients, excipients, and NOx-free air) successfully suppressed the formation of nitroso-atomoxetine to 0.097 ppm","author":"Nomura","year":"2025","journal-title":"Org Process Res Dev"},{"issue":"2","key":"10.1016\/j.xphs.2026.104482_bib0026","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0378-4347(00)00328-5","article-title":"Rapid determination of nitrite by reversed-phase high-performance liquid chromatography with fluorescence detection","volume":"746","author":"Li","year":"2000","journal-title":"J Chromatogr B: Biomed Sci Appl"},{"issue":"1","key":"10.1016\/j.xphs.2026.104482_bib0027","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jps.20726","article-title":"Evaluation of hydroperoxides in common pharmaceutical excipients","volume":"96","author":"Wasylaschuk","year":"2007","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104482_bib0028","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1019117328935","article-title":"Generation of superoxide ions at oxide surfaces","volume":"8","author":"Anpo","year":"1999","journal-title":"Top Catal"},{"issue":"1","key":"10.1016\/j.xphs.2026.104482_bib0029","article-title":"Adsorbed oxygen ions and oxygen vacancies: their concentration and distribution in metal oxide chemical sensors and influencing role in sensitivity and sensing mechanisms","volume":"23","author":"Ciftyurek","year":"2022","journal-title":"Sens (Basel)"},{"issue":"4","key":"10.1016\/j.xphs.2026.104482_bib0030","article-title":"Factors influencing NO\u2082 adsorption\/reduction on microporous activated carbon: porosity vs. Surface chemistry","volume":"11","author":"Ghouma","year":"2018","journal-title":"Mater (Basel)"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:55:13Z","timestamp":1791345313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022354926003321"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104482","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excipient nitrite levels are not static material attributes: Nitrite generation from environmental NOx and implications for drug product manufacturing","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104482"}}